share_log

金活医药集团(01110)：储小平获委任为独立非执行董事

Kingworld Pharmaceutical Group (01110): Chu Xiaoping appointed as an independent non-executive director

Zhitong Finance ·  Aug 30 22:18

Kingworld Pharmaceutical Group (01110) announced that Dr. Chu Xiaoping has been appointed as an independent non-executive director, a member of the nomination committee, and a member of the remuneration committee and audit committee, effective September 1, 2024.

The SmartFinance app reported that Dr. Chu Xiaoping of Kingworld Pharmaceutical Group (01110) has been appointed as an independent non-executive director, a member of the nomination committee, a member of the remuneration committee and audit committee, effective September 1, 2024.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment